The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story NIH director: Lack of public trust led ...

Dr. David Wohl — an infectious disease researcher with UNC Health — speaks with 97.9 The Hill's Brighton McConnell on Wednesday, August 13.

Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

Natalie Feagin, the executive director of the Clifton School, a day care that serves CDC and Emory employees at two locations ...

As the nation gears up for the rollout of an updated COVID-19 vaccine, a new study shows the economic benefits of continued ...

Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage trial, joining multiple biotech companies that have lost government funding for their ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...